Will Orexigen Have the Last Laugh?

• Report this Comment On January 07, 2013, at 3:17 PM, RSRdriver wrote:

  Even though something tells me your mom's basement is behind that screen, you actually make a lot of good points.

  When one looks at the Vivus/J+J lawsuit potential and Arena's efficacy and Eisai entanglements, OREX is really the only real buyout candidate as well.

• Report this Comment On January 07, 2013, at 5:23 PM, TMFMassimo wrote:

  @RSRdriver, thanks for the comment! In terms of a potential buy-out, it's important to note that Orexigen has a partnership agreement in place with Takeda for the commercialization of Contrave.

• Report this Comment On January 08, 2013, at 10:08 AM, Jinmeif88 wrote:

  Just forget about Contrave for a while. The required testing procedures will not complete until early 2014 plus the time to resubmit the application -- and the FDA review time, --- So take a nap, a good nap for that one.

• Report this Comment On January 08, 2013, at 12:32 PM, RSRdriver wrote:

  The play on OREX is into the event stage which should start this quarter. No one here is recomending a long term investment. If you don't know what a trade is, stick to the BS slinging on the ARNA message boards.

• Report this Comment On January 08, 2013, at 1:04 PM, MannyGoldberg wrote:

  I am an experienced Bariatric Physician, well versed in medical treatment of obesity, as well as FDA approval, as a former Principla Investigator.

  It is humorous to read the author's positive comments about Contrave, which is a long way from FDA approval. I recoomend you take a Wellbutrin daily as well as Narcan daily for a week, and report back how you feel.

  Wellbutrin makes many patients feel like a "zombie" and Narcan will reverse any pain-relieving narcotic like medications, throwing them into "cold turkey" withdrawal pain..

  Can you see a zombie in pain actually wanting to refill a Rx for Contrave, even if it is approved?

• Report this Comment On January 08, 2013, at 1:09 PM, RSRdriver wrote:

  Another Areniac "doctor". Just what ARNA longs need.

  You guys do more harm to the PPS than the puny efficacy. Keep it coming DH's.

• Report this Comment On January 08, 2013, at 1:22 PM, MannyGoldberg wrote:

  RS Driver,

  You are right........ I have over 250 patients (many are also diabetics) I plan to start on Belviq (I already have over 50 on Qsymia). I hate writing Rxs for Qsymia, like many M.D.s, but many I plan to switch to Belviq when they plateau. Contrave I dont ever plan to use, like many of my bariatric colleagues,

• Report this Comment On January 08, 2013, at 1:25 PM, RSRdriver wrote:

  This Areniac BS is getting old. Try that crap over at the Yahoo Message board.

• Report this Comment On January 08, 2013, at 1:26 PM, MannyGoldberg wrote:

  RS Driver,

  One more thing.....the efficacy issue is solid with Belviq....8% in a year, with 25% losing over 16%! This might not sound like much to the lay public, but it definitely makes a huge difference in

  blood sugar control, back pain, sleep apnea, and the horrible chronic pain of osteoarthritis.

• Report this Comment On January 08, 2013, at 1:30 PM, RSRdriver wrote:

  I see your slinging Reza's numbers. You guy's are hilarious. EVERYONE KNOWS BELVIQ IS USELESS!

• Report this Comment On January 08, 2013, at 1:36 PM, MannyGoldberg wrote:

  Sounds like you are already taking Contrave.....LOL.

  Unfortunately for you, you are wrong, but you won't be writing the Rxs, will you?.....

  Guess who will??

• Report this Comment On January 08, 2013, at 1:45 PM, RSRdriver wrote:

  You know, there SEC laws in place that are specifically used to cover fraud by impersonation. Check them out.

Add your comment.